Short Description Shift Bioscience CEO using AI to design age‑resetting gene edits.
Description Cambridge biologist Daniel Ives founded Shift Bioscience to apply machine learning on single‑cell epigenomic data and pinpoint ‘driver’ transcription factors for rejuvenation. His team employs CRISPRa screens to emulate the rejuvenome reset observed in embryogenesis without dedifferentiation. Ives coined the term ‘practical human rejuvenation’ and publishes open progress dashboards to foster transparency.